Systemic Therapy for Very High Risk to Oligometastatic Prostate Cancer
Doc Wire News,
The latest developments in systemic therapy for very high-risk localized and oligometastatic prostate cancer were reviewed…
The latest developments in systemic therapy for very high-risk localized and oligometastatic prostate cancer were reviewed…
Oncology/Hematology > Prostate Cancer Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup…
One-fifth of men with high-risk localized prostate cancer (PCa) receive treatment that is not standard of care, according to a…
Adding docetaxel to androgen suppression and radiation therapy for selected men with high-risk localized prostate cancer (PCa…